Non-Current Assets
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)
Amgen Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) decreased by 4.3% to $2.20B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.20B to $2.20B.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ1 2016
Last reportedQ1 2026Apr 30, 2026
Metric ID:
finite_lived_intangible_assets_amortization_year_1Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.20B | $2.20B | $1.70B | $1.70B | $1.80B | $2.10B | $2.10B | $2.10B | $2.90B | $2.90B | $2.90B | $2.20B | $2.30B | $2.30B | $2.20B |
| QoQ Change | — | +0.0% | -22.7% | +0.0% | +5.9% | +16.7% | +0.0% | +0.0% | +38.1% | +0.0% | +0.0% | -24.1% | +4.5% | +0.0% | -4.3% |
| YoY Change | — | — | — | -22.7% | -18.2% | +23.5% | +23.5% | +16.7% | +38.1% | +38.1% | +38.1% | -24.1% | -20.7% | -20.7% | +0.0% |
Range$1.70B – $2.90B
CAGR+0.0%
Avg YoY Growth+6.0%
Median YoY Growth+8.3%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) at Other Companies
Frequently Asked Questions
- What is Amgen's finite-lived intangible assets - expected amortization expense (year one)?
- Amgen (AMGN) reported finite-lived intangible assets - expected amortization expense (year one) of $2.20B in Q1 2026.
- How has Amgen's finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?
- Amgen's finite-lived intangible assets - expected amortization expense (year one) decreased by 0.0% year-over-year, from $2.20B to $2.20B.